Selection of cognitive tests for trials of therapeutic agents

The Lancet Psychiatry

Volumn 3, Issue 6, 2016, Pages 499-

  Harrison, John E ^a,b   Lam, Raymond W ^c   Baune, Bernhard T ^d   McIntyre, Roger S ^e  

^a METIS COGNITION LTD   (United Kingdom)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^c UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^d UNIVERSITY OF ADELAIDE   (Australia)

^e TORONTO WESTERN HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; PLACEBO;

COGNITION; COGNITIVE TEST; CONTROLLED CLINICAL TRIAL (TOPIC); DEPRESSION; HUMAN; LETTER; MENTAL DISEASE ASSESSMENT; WORKING MEMORY; COGNITIVE DEFECT; LONGITUDINAL STUDY;

ANTIDEPRESSIVE AGENTS; COGNITION; COGNITIVE DYSFUNCTION; DEPRESSION; HUMANS; LONGITUDINAL STUDIES;

EID: 84971373036     PISSN: 22150366     EISSN: 22150374     Source Type: Journal    
DOI: 10.1016/S2215-0366(16)30067-0     Document Type: Letter

References (4)

1. Shilyansky C, Williams LM, Gyurak A, Harris A, Usherwood T, Etkin A Effect of antidepressant treatment on cognitive impairments associated with depression: a randomised longitudinal study. Lancet Psychiatry 2016, published online March 16. http://dx.doi.org/10.1016/S2215-0366(16)00012-2.
2. Keefe RSE Treating cognitive impairment in depression: an unmet need. Lancet Psychiatry 2016, published online March 16. http://dx.doi.org/10.1016/S2215-0366(16)00095-X.
3. Harrison JE Measuring the mind: detecting cognitive deficits and measuring cognitive change in patients with depression. Cognitive dysfunction in major depressive disorder 2016, 229-241. Cambridge University Press, Cambridge. R.S. McIntyre, D. Cha (Eds.).
4. McIntyre RS A vision for drug discovery and development: novel targets and multilateral partnerships. Adv Ther 2014, 31:245-246.